Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000546798 | SCV000626675 | benign | Glycogen storage disease type III | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000616869 | SCV000732784 | likely benign | not specified | 2018-02-02 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genome- |
RCV000546798 | SCV002055058 | benign | Glycogen storage disease type III | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003942734 | SCV004758496 | likely benign | AGL-related disorder | 2020-10-02 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Natera, |
RCV000546798 | SCV002091503 | likely benign | Glycogen storage disease type III | 2019-12-10 | no assertion criteria provided | clinical testing |